Tower Research Capital LLC (Trc) Atai Life Sciences N.V. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 17,225 shares of ATAI stock, worth $21,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,225
Previous 8,670
98.67%
Holding current value
$21,359
Previous $17,000
29.41%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ATAI
# of Institutions
99Shares Held
12.7MCall Options Held
9.2KPut Options Held
118K-
Walleye Capital LLC Plymouth, MN2.76MShares$3.43 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.72MShares$3.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.62 Million0.0% of portfolio
-
Brown University719KShares$890,9400.39% of portfolio
-
Two Sigma Investments, LP New York, NY717KShares$889,2420.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $206M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...